In short, the answer is yes. The price of non-funded medication is completely at the discretion of the pharmacy selling it, the Pharmaceutical Society confirmed to Stuff. “Pharmacies are also ...

Is this ASX stock a healthy buying opportunity? The post Should I buy Sigma Healthcare shares for the Chemist Warehouse ...

Black Friday sale are here and these are the best skincare deals to shop that are live now, from brands like The Ordinary, ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the ...

The AARP is a host of many great things—nonprofit, advocate, even publisher. However, for many of its members, it's also a ...

Still squirming from the last 'bargain' that turned into an expensive mistake? Well don't let that put you off, because with most stores now slashing their prices by up to 50% you can't afford to miss ...

The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing ...

With eight years of experience as a financial journalist and editor and a degree in economics, Elizabeth Aldrich has worked on thousands of articles within the realm of banking, economics, credit ...

New Zealand dairy giant Fonterra is considering selling its Sri Lankan business. In a statement today, Fonterra Co-operative Group Ltd announced it is exploring "full or partial divestment options" ...